Article

Video blog: Test could spare some DCIS patients from radiation

Author(s):

Debu Tripathy

Dr. Debu Tripathy discusses how a test, a variation of the Oncotype DX test, could help physicians decide on radiation therapy for their patients diagnosed with ductal carcinoma in situ (DCIS).

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
2 experts are featured in this series.
2 experts are featured in this series.
Immune Therapy Expands Melanoma Treatment to More Patients
Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment plan.
image of doctor D'Sa
2 experts are featured in this series.
2 experts are featured in this series.
Image of Dr. Eng.
Image of Dr. Tagawa.
Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact on treatment outcomes.
Related Content
Blood cell.
May 8th 2025

Navigating Lymphoma and Survivorship in Adolescents and Young Adults

Ryan Scott
Dr. Kara Kelly discusses the unique challenges that adolescent and young adult patients with cancer face following their diagnosis.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Lung cancer remains the leading cause of cancer-related deaths in the U.S.
May 7th 2025

Breaking Barriers: Why Increasing Lung Screening is Critical

Lung Cancer Initiative (LCI)
Lung cancer remains the leading cause of cancer-related deaths in the U.S.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
May 7th 2025

Managing Lung Inflammation After Chemoradiation and Tagrisso

Dr. Suresh S. Ramalingam
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
LCI proudly participated in the GO2 Voices Summit.
May 7th 2025

LCI Shows Support for Lung Cancer Research Funding at GO2 Voices Summit

Lung Cancer Initiative (LCI)
Lung Cancer Initiative proudly participated in the GO2 Voices Summit held March 9–11, 2025, in Washington, DC.